News
There are only four FDA approved drugs to alleviate symptoms of #AlzheimersDisease but none that treat the disease. #CompChem is a valuable resource in helping to characterize and understand new protein targets. bit.ly/2KItgc0 #DrugDiscovery #MoleculeDesign #Alzheimers pic.twitter.com/nDjHtGi5ZR
The question that many of the people talking to Cresset Discovery Services ask is “I have discovered some interesting biology – how ...
Biological data is now a regular feature of new patent applications and this is readily available for download from Bindingdb which has ...
Novartis Institutes for Biomedical Research recently published the paper Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, ...
Comparing Forge’s command line utility to Blaze – which one should you use? Here at Cresset we’re very interested in ...
Bayer AG recently published an interesting paper on the discovery of potent and selective SOS1 inhibitors that block RAS activation via ...
We have been working steadily to convert our initial prototype into a full product
Talking to a group of medicinal chemists at a conference over lunch raised the following question: “It’s really interesting to see ...
Here at Cresset we’re very interested in ligand-based virtual screening – it’s been a focus of the company ever since ...
Forge V10.6 released We are delighted to announce the availability of Forge™ V10.6, our powerful computational chemistry suite for understanding ...
What can Torch users expect from Forge Design?
The focus of this release is on new and improved methods to generate robust Quantitative Structure-Activity Relationship (QSAR) models with ...
Antibodies are fantastically versatile molecular recognition engines, capable of creating artificial enzymes in response to recognized interactions. Similarly, enzymes depend ...